{"Symbol": "ADHD", "AssetType": "Common Stock", "Name": "Alcobra Ltd", "Description": "Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary pharmaceutical products. The company? s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Alcobra Ltd. was founded in 2008 and is headquartered in Tel Aviv, Israel.", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "Other", "Industry": "Other", "Address": "Azrieli Triangle Building, 39th Floor, 132 Derech Menachem B\n6701101,Tel Aviv,ISR\n", "FullTimeEmployees": "0", "FiscalYearEnd": "December", "LatestQuarter": "None", "MarketCapitalization": "0", "EBITDA": "-21410000", "PERatio": "None", "PEGRatio": "0", "BookValue": "1.48", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.76", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "0", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "1.67", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "0", "PriceToBookRatio": "0", "EVToRevenue": "0", "EVToEBITDA": "0", "Beta": "None", "52WeekHigh": "None", "52WeekLow": "None", "50DayMovingAverage": "0", "200DayMovingAverage": "0", "SharesOutstanding": "0", "SharesFloat": "0", "SharesShort": "0", "SharesShortPriorMonth": "0", "ShortRatio": "0", "ShortPercentOutstanding": "0", "ShortPercentFloat": "0", "PercentInsiders": "0", "PercentInstitutions": "0", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}